The treatment of hypertension in patients with erectile dysfunction

被引:25
|
作者
Mikhailidis, DP
Khan, MA
Milionis, HJ
Morgan, RJ
机构
[1] UCL Royal Free & Univ Coll Med Sch, Dept Mol Pathol & Clin Biochem, London NW3 2QG, England
[2] UCL Royal Free & Univ Coll Med Sch, Dept Urol, London NW3 2QG, England
关键词
beta-blockers; diuretics; doxazosin; erectile dysfunction; hypertension;
D O I
10.1185/0300799009117037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is another predictor of erectile dysfunction (ED). This is further evidence supporting a link between the pathogenesis of atherosclerotic disease ann ED. In one study (TOMHS) involving hypertensive patients, the incidence of ED was 14.4%. The drugs used to treat hypertension may cause ED. However, there is little trial-based evidence to indicate which drugs are more likely to cause this side effect. In general, thiazide diuretics and beta-blockers seem to cause ED more often. In contrast, the alpha-blocker doxazosin, has Mot been associated with an increased incidence of ED as a sine effect. Doxazosin also improves urinary flow in patients with benign prostatic hyperplasia (BPH). This condition is common in elderly men as is hypertension and ED. Therefore, doxazosin may present a special advantage among this group of patients. This alpha-blocker would also be a good choice in patients with impaired glucose tolerance/diabetes because it improves insulin sensitivity. Moreover, ED and hypertension are more prevalent among diabetics. On a more speculative note, doxazosin may potentiate the therapeutic impact of specific treatments for ED.
引用
收藏
页码:S31 / S36
页数:6
相关论文
共 50 条
  • [21] CORRELATION BETWEEN URIC ACID LEVEL AND ERECTILE DYSFUNCTION IN CONTROLLED HYPERTENSION MALE PATIENTS
    Sengkey, R.
    Sugeng, C.
    Umboh, O.
    Palar, S.
    Moeis, E. S.
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 2) : E9 - E9
  • [22] Management of Erectile Dysfunction: An Under-recognition of Hypertension
    Koroglu, Gokhan
    Kaya-Sezginer, Ecem
    Yilmaz-Oral, Didem
    Gur, Serap
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (30) : 3506 - 3519
  • [23] Impact of Treatment With Sacubitril/Valsartan on Erectile Dysfunction in Patients With Heart Failure
    Barman, Hasan Ali
    Dogan, Omer
    Tanyolac, Selim
    Atici, Adem
    Arabaci, Hidayet Ozan
    Ebeoglu, Abdullah Omer
    Ozyildirim, Serhan euro
    Yigit, Zerrin
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 212 : 1 - 5
  • [24] Treatment of erectile dysfunction
    Dinsmore, W
    INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (04) : 215 - 221
  • [25] The Treatment of Erectile Dysfunction
    Gambescia, Nancy
    Sendak, Shelley
    Weeks, Gerald
    JOURNAL OF FAMILY PSYCHOTHERAPY, 2009, 20 (2-3) : 221 - 240
  • [26] Treatment of erectile dysfunction
    Opsomer, RJ
    ACTA CLINICA BELGICA, 2002, 57 (05) : 272 - 276
  • [27] Hypertension is associated with severe erectile dysfunction
    Burchardt, M
    Burchardt, T
    Baer, L
    Kiss, AJ
    Pawar, RV
    Shabsigh, A
    De la Taille, A
    Hayek, OR
    Shabsigh, R
    JOURNAL OF UROLOGY, 2000, 164 (04) : 1188 - 1191
  • [28] Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the erectile dysfunction observational study
    Haro, JM
    Beardsworth, A
    Casariego, J
    Gavart, S
    Hatzichristou, D
    Martin-Morales, A
    Schmitt, H
    Mirone, V
    Needs, N
    Riley, A
    Varanese, L
    Von Keitz, A
    Kontodimas, S
    JOURNAL OF SEXUAL MEDICINE, 2006, 3 (03) : 530 - 540
  • [29] Pathophysiology of erectile dysfunction
    de Tejada, IS
    Angulo, J
    Cellek, S
    González-Cadavid, N
    Heaton, J
    Pickard, R
    Simonsen, U
    JOURNAL OF SEXUAL MEDICINE, 2005, 2 (01) : 26 - 39
  • [30] Quality of life in patients with erectile dysfunction
    Celada Rodriguez, Angel
    Tarraga Lopez, Pedro Juan
    Rodriguez Montes, Jose Antonio
    Solera Albero, Juan
    Lopez Cara, Mateo A.
    Arjona Laborda, Enrique
    REVISTA INTERNACIONAL DE ANDROLOGIA, 2012, 10 (01): : 11 - 20